2025-2034 Growth Prospects of the Antivirals Market: Key Trends and Opportunities Analyzed
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Significant is the Anticipated Growth Rate of the Antivirals Market from 2025 to 2034?
The size of the antivirals market has seen considerable growth in the past few years. The market is projected to increase from $106.13 billion in 2024 to $114.7 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. This growth during the historic period can be associated with the high occurrence of viral diseases, concerns about public health, the expiration of patents, and initiatives taken by the government.
The market size for antivirals is anticipated to experience robust expansion in the upcoming years. It’s predicted to surge to a value of $153.67 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. The projected growth over this period could be attributed to the rise in viral threats and worldwide health initiatives. Key trends for this forecast period involve advancements in technology, a shift towards telemedicine and digital health, as well as personalized medicine.
How Are the key drivers expanding the growth of the Antivirals Market?
The surge in occurrences of influenza is projected to drive the expansion of the antiviral market. Influenza, colloquially known as the flu, is a contagious viral infection that affects the respiratory system primarily the nose, throat, and lungs, caused by influenza viruses. Antivirals serve as a treatment method for influenza, designed to constrain the duplication and dissemination of the influenza virus within the human body. To illustrate, the Centers for Disease Control and Prevention, a health organization from the US, reported in October 2022, that there were 9 million flu diseases, 4 million medical appointments related to flu, 100,000 hospitalizations due to flu, and 5,000 deaths resulting from influenza during the 2021-2022 season. Hence, the escalating prevalence of influenza fosters the development of the antiviral market.
Get Your Free Sample of the Global Antivirals Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp
Who Are the Dominant Players Pushing the Boundaries of the Antivirals Market?
Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.
How Are Market Trends Revolutionizing the Antivirals Industry in Recent Times?
Key players in the antiviral market, such as Pfizer, are striving towards the development of groundbreaking therapies like oral antiviral treatment. This effort is aimed at enhancing patient comfort, promoting accessibility, lowering healthcare expenses, and offering more efficient and convenient choices for managing viral infections. Essentially, oral antiviral treatments are medications consumed orally to combat viral infections. They function by limiting the capacity of viruses to replicate or spread inside the body, thus mitigating the intensity and span of the infection. To illustrate, in May 2023, Pfizer, a prominent pharmaceutical company headquartered in the US, announced the Food and Drug Administration’s approval of Paxlovid, establishing it as the inaugural oral antiviral treatment for adult COVID-19 patients. This endorsement is particularly noteworthy as it introduces a fresh treatment alternative for managing COVID-19, particularly in a scenario where the pandemic is evolving into an endemic phase. Paxlovid is specifically prescribed for adults with mild to moderate COVID-19 who have a high likelihood of progressing to severe disease or requiring hospitalization or even leading to death.
Get Instant Access to the Global Antivirals Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report
What Are the Key Components of the Antivirals Market, and How Do Its Segments Perform?
The antivirals market covered in this report is segmented –
1) By Type: Branded, Generic
2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes
3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications
Subsegments:
1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)
2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals
Which Geographic Areas Are Influencing the Growth of the Antivirals Market?
North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
How Can We Define the Antivirals Market and Its Key Components?
Antivirals are medications designed to treat viral infections by inhibiting the replication of viruses within the host’s cells. Unlike antibiotics, which target bacteria, antivirals are specifically used to combat viruses such as the flu, HIV, or hepatitis. They work by interfering with various stages of a virus’s lifecycle, helping to reduce the severity and duration of an infection.
Browse Through More Similar Reports By The Business Research Company:
Liposomal Drug Delivery Devices Global Market Report 2024
COVID-19 Drug Associated APIs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report
Hospital Acquired Infections Testing Kits Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
